• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

将胃肠道生活质量指数映射到短式 6D 效用评分。

Mapping the Gastrointestinal Quality of Life Index to short-form 6D utility scores.

机构信息

Department of Surgery, Steinberg-Bernstein Centre for Minimally Invasive Surgery and Innovation, McGill University Health Centre, Montreal, Canada.

出版信息

J Surg Res. 2014 Jan;186(1):135-41. doi: 10.1016/j.jss.2013.08.006. Epub 2013 Aug 28.

DOI:10.1016/j.jss.2013.08.006
PMID:24021906
Abstract

PURPOSE

The Gastrointestinal Quality of Life Index (GIQLI) is a disease-specific quality of life instrument that is commonly used in gastrointestinal disorders. However, no preference weights, which are used to calculate quality-adjusted life years for cost-effectiveness analyses, for this instrument have been assigned. Therefore, the objective of this study was to develop a mapping function to derive utility scores for the GIQLI.

METHODS

Patients undergoing elective laparoscopic cholecystectomy completed the short-form 6D (SF-6D), a preference-weighted utility measure, and the GIQLI at baseline and at 1 wk and 1 mo postoperatively. The responsiveness of the SF-6D to expected postoperative changes as well as the correlation between the SF-6D and the GIQLI was investigated. Ordinary least squares regression was performed to derive a mapping function using the baseline values, which was then validated using postoperative values. Adjusted r(2), mean absolute error, and root mean square error was used to determine model performance.

RESULTS

A total of 50 patients were included in the study (mean age 51.1 [standard deviation 16.8], 28% male). The SF-6D and GIQLI domains were responsive to expected postoperative changes, and there was high correlation between the SF-6D and four of the five GIQLI domains (excluding treatment effects). The final mapping function explained 63% of the variance in the derivation sample but had relatively high mean absolute error (0.075 and 0.067 in the 1-wk and 1-mo samples, respectively) and adjusted root mean square error (13.1% and 12.0% in the 1-wk and 1-mo samples, respectively).

CONCLUSIONS

The GIQLI can be accurately mapped to SF-6D preference weights at the group level but may be too inexact at the individual level.

摘要

目的

胃肠道生活质量指数(GIQLI)是一种常用于胃肠道疾病的特定于疾病的生活质量工具。然而,对于这种仪器,尚未分配用于成本效益分析的质量调整生命年的偏好权重。因此,本研究的目的是开发一种映射函数,以得出 GIQLI 的效用得分。

方法

接受择期腹腔镜胆囊切除术的患者在基线、术后 1 周和 1 个月时完成了简短 6 维度(SF-6D)、偏好加权效用衡量标准和 GIQLI。研究了 SF-6D 对预期术后变化的反应能力以及 SF-6D 与 GIQLI 的相关性。使用基线值进行普通最小二乘回归以得出映射函数,然后使用术后值进行验证。使用调整后的 r(2)、平均绝对误差和均方根误差来确定模型性能。

结果

共纳入 50 例患者(平均年龄 51.1 [标准差 16.8],28%为男性)。SF-6D 和 GIQLI 域对预期的术后变化敏感,SF-6D 与 GIQLI 的四个域(不包括治疗效果)之间存在高度相关性。最终的映射函数在推导样本中解释了 63%的方差,但平均绝对误差相对较高(1 周和 1 个月样本分别为 0.075 和 0.067),调整后的均方根误差也较高(1 周和 1 个月样本分别为 13.1%和 12.0%)。

结论

GIQLI 可以在组水平上准确映射到 SF-6D 偏好权重,但在个体水平上可能不够精确。

相似文献

1
Mapping the Gastrointestinal Quality of Life Index to short-form 6D utility scores.将胃肠道生活质量指数映射到短式 6D 效用评分。
J Surg Res. 2014 Jan;186(1):135-41. doi: 10.1016/j.jss.2013.08.006. Epub 2013 Aug 28.
2
The development of a model for translation of the Neck Disability Index to utility scores for cost-utility analysis in cervical disorders.开发一种将 Neck Disability Index (NDI)转化为颈椎疾病成本效用分析中效用评分的模型。
Spine J. 2012 Jan;12(1):55-62. doi: 10.1016/j.spinee.2011.12.002. Epub 2011 Dec 29.
3
Valuing postoperative recovery: validation of the SF-6D health-state utility.重视术后恢复:SF-6D 健康状态效用的验证。
J Surg Res. 2013 Sep;184(1):108-14. doi: 10.1016/j.jss.2013.02.034. Epub 2013 Mar 13.
4
Predicting SF-6D from the European Organization for Treatment and Research of Cancer Quality of Life Questionnaire scores in patients with colorectal cancer.预测结直肠癌患者欧洲癌症研究与治疗组织生活质量问卷评分的 SF-6D 得分。
Value Health. 2013 Mar-Apr;16(2):373-84. doi: 10.1016/j.jval.2012.12.004.
5
Using the Multiple Sclerosis Impact Scale to estimate health state utility values: mapping from the MSIS-29, version 2, to the EQ-5D and the SF-6D.使用多发性硬化症影响量表来估算健康状态效用值:从 MSIS-29 版本 2 到 EQ-5D 和 SF-6D 的映射。
Value Health. 2012 Dec;15(8):1084-91. doi: 10.1016/j.jval.2012.07.007. Epub 2012 Nov 4.
6
Mapping chronic liver disease questionnaire scores onto SF-6D utility values in patients with primary sclerosing cholangitis.原发性硬化性胆管炎患者慢性肝病问卷评分与SF-6D效用值的映射关系
Qual Life Res. 2016 Apr;25(4):947-57. doi: 10.1007/s11136-015-1161-x. Epub 2015 Oct 15.
7
Mapping the Functional Assessment of Cancer Therapy-general or -Colorectal to SF-6D in Chinese patients with colorectal neoplasm.将癌症治疗功能评估-一般或-结直肠量表与中国结直肠肿瘤患者的 SF-6D 进行映射。
Value Health. 2012 May;15(3):495-503. doi: 10.1016/j.jval.2011.12.009. Epub 2012 Feb 17.
8
Quality of life in cochlear implantees: comparing utility values obtained through the Medical Outcome Study Short-Form Survey-6D and the Health Utility Index Mark 3.人工耳蜗植入者的生活质量:比较通过医学结局研究简表调查-6D和健康效用指数Mark 3获得的效用值。
Laryngoscope. 2014 Nov;124(11):2586-90. doi: 10.1002/lary.24648. Epub 2014 Aug 11.
9
A comparison of the validity of two indirect utility instruments as measures of postoperative recovery.两种间接效用工具作为术后恢复测量指标的有效性比较。
J Surg Res. 2014 Jul;190(1):79-86. doi: 10.1016/j.jss.2014.02.016. Epub 2014 Feb 15.
10
Comparison of the EuroQol and short form 6D in Singapore multiethnic Asian knee osteoarthritis patients scheduled for total knee replacement.新加坡计划进行全膝关节置换术的多民族亚洲膝骨关节炎患者中欧洲五维健康量表与简版6D量表的比较
Arthritis Rheum. 2007 Aug 15;57(6):1043-9. doi: 10.1002/art.22883.

引用本文的文献

1
Health utility values for patients with recurrent acute rhinosinusitis undergoing endoscopic sinus surgery: a nested case control study.接受鼻内镜鼻窦手术的复发性急性鼻窦炎患者的健康效用值:一项巢式病例对照研究。
Int Forum Allergy Rhinol. 2016 Nov;6(11):1182-1187. doi: 10.1002/alr.21809. Epub 2016 Jun 16.
2
PREFERRED REPORTING ITEMS FOR STUDIES MAPPING ONTO PREFERENCE-BASED OUTCOME MEASURES: THE MAPS STATEMENT.基于偏好的结局测量研究的首选报告项目:MAPS声明。
Int J Technol Assess Health Care. 2015 Jan;31(4):230-5. doi: 10.1017/S0266462315000379. Epub 2015 Aug 3.
3
Preferred reporting items for studies mapping onto preference-based outcome measures: The MAPS statement.
映射到基于偏好的结局指标的研究的首选报告项目:MAPS声明。
Health Qual Life Outcomes. 2015 Aug 1;13:106. doi: 10.1186/s12955-015-0305-6.
4
Preferred Reporting Items for Studies Mapping onto Preference-Based Outcome Measures: The MAPS Statement.映射到基于偏好的结局指标的研究的首选报告项目:MAPS声明。
Pharmacoeconomics. 2015 Oct;33(10):985-91. doi: 10.1007/s40273-015-0319-2.
5
The MAPS Reporting Statement for Studies Mapping onto Generic Preference-Based Outcome Measures: Explanation and Elaboration.适用于基于通用偏好的结局指标的映射研究的MAPS报告声明:解释与阐述
Pharmacoeconomics. 2015 Oct;33(10):993-1011. doi: 10.1007/s40273-015-0312-9.
6
Preferred Reporting Items for Studies Mapping onto Preference-Based Outcome Measures: The MAPS Statement.映射到基于偏好的结局指标的研究的首选报告项目:MAPS声明。
Appl Health Econ Health Policy. 2015 Oct;13(5):437-43. doi: 10.1007/s40258-015-0191-4.
7
Preferred reporting items for studies mapping onto preference-based outcome measures: the MAPS statement.映射到基于偏好的结局指标的研究的首选报告项目:MAPS声明。
Qual Life Res. 2016 Feb;25(2):275-281. doi: 10.1007/s11136-015-1082-8. Epub 2015 Aug 1.